Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2019-02-28 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a notice published to shareholders regarding the transfer of unclaimed equity shares to the Investor Education and Protection Fund (IEPF) Suspense Account as per regulatory rules. It includes details about the unclaimed dividends from 2011, the procedure for shareholders to claim back shares, and contact information for queries. The document is a formal announcement to shareholders and stock exchanges about this transfer process, not a financial report or detailed analysis. It does not contain financial statements, audit information, or management discussion. The document length is about 5984 characters, which is relatively short and consistent with a notice or announcement. Therefore, this document fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement that does not fit into other specific categories like Annual Report, Interim Report, or Dividend Notice.
2019-02-28 English
Please find enclosed copies of the Notice to shareholders of the Company published today, in newspapers, Business Standard and Sakal.
Report Publication Announcement Classification · 95% confidence The document is a notice published to shareholders regarding the transfer of unclaimed equity shares to the Investor Education and Protection Fund (IEPF) Suspense Account as per regulatory rules. It includes details about the unclaimed dividends from 2011, the procedure for transfer, and contact information for queries. The document is a formal announcement to shareholders and stock exchanges about this regulatory compliance action. It does not contain financial statements, audit results, management discussion, or detailed financial data. It is not a report itself but a notice publication. Therefore, it fits the category of Report Publication Announcement (RPA) as it announces a regulatory action and provides information to shareholders without being a full report or financial filing.
2019-02-28 English
Sanofi India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 30, 2019 to May 07, 2019 (both days inclusive) for the ....
Notice of Dividend Amount Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the outcome of a Board Meeting. It includes the recommendation for a final dividend, the date for the Annual General Meeting (AGM), and the book closure dates. The document is short (1239 characters) and serves as an announcement of decisions made by the Board rather than a detailed report or financial statement. It specifically announces dividend payment details and AGM scheduling, which aligns with the category 'Notice of Dividend Amount' (DIV). It is not a full Annual Report, Earnings Release, or AGM Information presentation. Therefore, the appropriate classification is DIV with high confidence.
2019-02-27 English
Financial Result Updates
Regulatory Filings
2019-02-27 English
AGM/Book Closure
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 113 characters, indicating it is extremely short and does not contain any report content. It is likely a placeholder or an announcement with no detailed information. According to the MENU VS MEAL RULE, such a short document without actual report content should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Given the lack of any textual content or indication of report publication, the safest classification is Regulatory Filings (RNS) as a fallback category.
2019-02-27 English
We refer to our letter dated 11th February 2019 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 12.00 noon and concluded at 04.30 p.m. ....
Notice of Dividend Amount Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the outcome of a Board Meeting. It includes information about the recommendation for a final dividend, the date for the Annual General Meeting (AGM), and the book closure dates. The document does not contain detailed financial statements or comprehensive report content but rather announces decisions made by the Board. The document length is short (1239 characters), and it serves as an official announcement of dividend and AGM scheduling. Therefore, it fits best under the category of Notice of Dividend Amount (DIV) because it announces dividend payment details and related shareholder meeting dates.
2019-02-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.